首頁 › 急性淋巴母細胞性白血病 › 喬治亞 › Atlanta
Atlanta, GA 的 急性淋巴母細胞性白血病 臨床試驗
19 項針對 急性淋巴母細胞性白血病 的研究正在 Atlanta（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
招募中
- Children's Healthcare of Atlanta, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Atlanta VA Medical Center, Decatur · 距離 6 英里
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中觀察性研究
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
招募中1 期
- Emory University, Atlanta
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
招募中2 期
- Children's Hospital of Atlanta, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- Emory Winship Cancer Institute, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
招募中2 期
- Children's Healthcare of Atlanta at Egleston, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
招募中1 期歡迎健康志工
- Northside Hospital, Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中觀察性研究
- Children's Healthcare of Atlanta - Egleston, Atlanta
Pilot Imaging Study of Leukemia
招募中1 期
- Emory University, Atlanta
CAR T-cell Therapy in Patients With Renal Dysfunction
招募中2 期
- Caitlin Guzowski, Atlanta
Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia
招募中2 期
- Northside Hospital, Atlanta
Venetoclax Basket Trial for High Risk Hematologic Malignancies
招募中1 期
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
招募中2 期歡迎健康志工
- Northside Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
招募中1 期
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
招募中1 期
- Winship Cancer Institute, Emory University, Atlanta
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Children's Healthcare of Atlanta, Emory University, Atlanta
其他城市的 急性淋巴母細胞性白血病 試驗
- Houston, TX28 項研究
- New York City, NY24 項研究
- Baldwin Park, CA21 項研究
- Seattle, WA21 項研究
- Chicago, IL19 項研究
- Memphis, TN16 項研究
- Philadelphia, PA16 項研究
- Washington, DC16 項研究
- Boston, MA15 項研究
- Los Angeles, CA14 項研究
- Durham, NC13 項研究
- Mountain View, CA13 項研究
Atlanta 的其他研究
- 癌症（所有類型）49 項研究
- 非小細胞肺癌47 項研究
- 乳癌41 項研究
- 多發性骨髓瘤41 項研究
- 前列腺癌33 項研究
- 急性髓系白血病30 項研究
- 卵巢癌29 項研究
- 肺癌29 項研究
- 大腸直腸癌29 項研究
- 轉移性癌症28 項研究
- 心臟衰竭25 項研究
- 重度憂鬱症25 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。